• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL COSTA RICA LTD. PRIMARY PLUM SET, CLAVE SECONDARY PORT, 2 CLAVE Y-SITES, 0.2 MICRON FILTER, SECU; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL COSTA RICA LTD. PRIMARY PLUM SET, CLAVE SECONDARY PORT, 2 CLAVE Y-SITES, 0.2 MICRON FILTER, SECU; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 142540489
Device Problem Fluid/Blood Leak (1250)
Patient Problems Chemical Exposure (2570); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/01/2023
Event Type  malfunction  
Manufacturer Narrative
Although the device was requested to be returned for evaluation, it has not been received.Without the returned device, a probable cause is unable to be determined.
 
Event Description
It was reported that on an unknown date a primary plum set, clave secondary port, 2 clave y-sites, 0.2 micron filter, secure lock, 112 inch sets are leaking in high frequency in the chemo suites during patient use.The medication involved was paclitaxel.There were two drops on the patient, drops were absorbed onto a blue pad, the patient's skin was cleansed, and instructions were provided for laundering clothing.The chemo drug came into contact with clothing.There was unprotected chemodrug exposure to the patient.The chemo drug spill was cleaned up per facility protocol.There were no holes, cuts, tears, or any defects noted.The affected sample was attached to a tubing set with a closed system transfer device - chemolock.It was also stated that the chemo was coming out of the two circles on the back of the filter case.There was patient involvement and no patient harm.
 
Manufacturer Narrative
An image of the inline filter of the primary plum set was provided by the customer.Received one (1) used list #142540489 primary plum set connected to a chemolock connector.There was no damage or anomalies noted on the set either set.The returned sample was leak-tested per product specifications.There were no leaks observed.The complaint of leakage cannot be confirmed on the returned used sample.The lot history was reviewed and no nonconformities were identified that may have contributed to the reported complaint.D9 - date returned to mfg: 1/29/2024.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRIMARY PLUM SET, CLAVE SECONDARY PORT, 2 CLAVE Y-SITES, 0.2 MICRON FILTER, SECU
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
ICU MEDICAL COSTA RICA LTD.
zona franca global
la aurora heredia
CS 
Manufacturer Contact
reed covert
600 n. field dr.
lake forest, IL 60045
2247062300
MDR Report Key18390052
MDR Text Key331318463
Report Number9615050-2023-00812
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K141789
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Followup
Report Date 03/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number142540489
Device Lot Number13684576
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/24/2023
Supplement Dates Manufacturer Received02/28/2024
Supplement Dates FDA Received03/07/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/01/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PACLITAXEL, UNK, MFR.
-
-